Psoriatic Arthritis

Latest News

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity
RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

March 19th 2023

A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA.

Opioid Use in Psoriatic Arthritis Is Associated With Higher Health Care Costs, Utilization
Opioid Use in Psoriatic Arthritis Is Associated With Higher Health Care Costs, Utilization

January 5th 2023

Defining a New Era for Patients with PsO and PsA
Defining a New Era for Patients with PsO and PsA

October 23rd 2022

Exploring the Relationship Between Psoriatic Arthritis and Psoriasis
Exploring the Relationship Between Psoriatic Arthritis and Psoriasis

October 5th 2022

Ustekinumab Approved by the FDA for Pediatric Patients with Psoriatic  Arthritis
Ustekinumab Approved by the FDA for Pediatric Patients with Psoriatic Arthritis

August 1st 2022

Video Interviews
Podcasts
The Cutaneous Connection

More News

© 2023 MJH Life Sciences

All rights reserved.